Drugmakers likely to be hit by new drug-pricing reform

The government’s plan to gradually lower drug prices, which is to be implemented in October, has stirred up concerns among drug companies.

They fear that the new initiative could not only slash their profits but push many marginal companies out of business. Many small companies are reported to have already started looking to big firms for merger deals.

The plan, if carefully and thorough...